Pioneering a Breakthrough in Eczema and Psoriasis Treatment
Kalm Therapeutics is developing the 1st Prescription Patch treatment for eczema and psoriasis.
Protect and Treat
The Kalm Patch will cover the affected skin, protecting it from scratching, infection and moisture loss; all of which are known disease drivers. In addition, our proprietary formulation delivers a continuous therapeutic dose to the epidermis over 24 hours, which will provide optimal efficacy. Our natural active ingredient is a proven safe, anti-inflammatory small molecule. This once-a-day patch will be a giant leap from harmful steroids and other topical creams, which provide no protection to the skin, require multiple doses per day, and deliver uneven dose levels to the epidermis.
Company Details
- Employees
- 4
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.kalmtherapeutics.com
- Keywords
- biotech, biopharma, immune, therapeutics.
Kalm Therapeutics Questions
Kalm Therapeutics's website is http://www.kalmtherapeutics.com
Kalm Therapeutics's LinkedIn profile is https://www.linkedin.com/company/kalm-therapeutics
Kalm Therapeutics has
4 employees.
View email and phone details for 4
employees at Kalm Therapeutics.
Kalm Therapeutics's industry is
Biotechnology Research
Kalm Therapeutics's top competitors are
Pop Therapeutics,
Serina Therapeutics, Inc.,
Curalinc Healthcare,
Hudsonalpha Institute For Biotechnology,
Histosonics, Inc.,
Cfd Research Corporation,
Bio Alabama,
Thrive Bioscience, Inc.,
Rxsavecard,
Setatech.
Kalm Therapeutics's categories are Biotechnology Research
